Search Results

Complete the form below and submit to SIU School of Medicine Office of Continuing Professional Development for processing.

Not all of us are born to be leaders, right? After all, if everyone led, who would be the followers? To be honest, I had fully embraced the role of being a behind-the-scenes individual, happy to bring things to fruition without any desire for acknowledgment. Although I was content, I had never identified myself as a leader. Little did I know, however, that hidden beneath the veil of anonymity, I too possessed the essence of leadership. When I thought of a leader, I envisioned someone like the President: articulate, charismatic, the center of attention. But as I have grown and progressed in my

Julio Barrenzuela is adept at overcoming cultural barriers. Now, in the midst of a pandemic, he holds hope that an SIU outreach program can improve the health of Springfield’s Latino and undocumented populations. In spring 2020, Barrenzuela joined SIU’s newly formed Illinois Virtual Care Program as a pandemic health worker (PHW), hired to build bridges between Springfield’s Spanish-speaking communities and its medical community. Since 2015, SIU Medicine has been making progress in neglected neighborhoods of Springfield, using community health workers to connect residents with social services

GMEC Leave of Absence Policy effective 7.2022 Program Specific Leave of Absence Protocol 7.2022 GMEC Leave of Absence Request Form 7.2022

General information Lecanemab is one of the first Alzheimer’s treatments designed to remove amyloid protein in the brain, and has been approved by the FDA for treatment of patients with “mild cognitive impairment” and mild dementia stages of Alzheimer’s disease. Generic name: lecanemab Brand name: Leqembi TM Made by: Eisai and Biogen What is it proven to do? Remove beta amyloid protein from the brain, which is one of the Alzheimer’s proteins. Slow the worsening of Alzheimer’s disease to a modest degree (27% over 18 months), based on the cognitive and functional test, Clinical Dementia Rating

SPRINGFIELD, IL – At work or in public, we sometimes witness microaggressions, disrespect, and racism directed at others. When something happens that goes against our values, there is often palpable discomfort, fear and uncertainty about what to do. Sunny Nakae, MSW, PhD, will offer skills and strategies for addressing these encounters at the 2022 Dr. Alonzo Kenniebrew Lecture, beginning at 6 pm, Tuesday, February 8. Nakae is senior associate dean for equity, inclusion, diversity and partnership at the California University of Science and Medicine. “Becoming an Ally” is the theme of the 2022

2019 Lecture Daniel E. Dawes, J.D. , was the 2019 Theodore R. LeBlang Distinguished Lecturer . His presentation was entitled: The Future of Health Equity in America . Dawes is a nationally recognized leader in the movement to advance health equity among under-resourced, vulnerable, and marginalized communities. An attorney, scholar, and health policy expert, Dawes serves as the Senior Advisor and General Counsel to the Satcher Health Leadership Institute at Morehouse School of Medicine in Atlanta, Georgia, and as an Associate Professor of Complex Health Systems at the H. Wayne Huizenga College

Medical Humanities hosts several visiting lecturers every year: Pearson Lecture: The lecture and museum are named in honor of Dr. Emmet F. Pearson, a Springfield physician who was also a professor emeritus in the internal medicine and medical humanities departments at SIU. He died in June 1996. Theodore R. LeBlang Distinguished Lectureship in Law and Medicine: Professor Theodore LeBlang was the mainstay of the Law and Medicine teaching program for every class of students who have graduated from the school since its inception in 1975. He retired in 2006.